Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Olfarma ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1000.0 Bankruptcy Risk  2018 N/A 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.1% 1.1%   Bankruptcy risk   0.0% 13.9% 9.1% 13.0% 7.1% 6.1% 16.8% 16.5%   Credit score (0-100)   0 17 27 16 33 37 10 11   Credit rating   N/A BB BB BB BBB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 N/A 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 42 0 0 0 0 0 0   Gross profit   0.0 11.3 38,516 72.5 445 408 0.0 0.0   EBITDA   0.0 11.3 38,516 72.5 214 105 0.0 0.0   EBIT   0.0 11.3 38,516 72.5 149 40.4 0.0 0.0   Pre-tax profit (PTP)   0.0 9.3 37,116.0 50.8 61.1 -12.6 0.0 0.0   Net earnings   0.0 7.3 28,950.0 39.7 42.7 -13.8 0.0 0.0   Pre-tax profit without non-rec. items   0.0 9.3 37,116 50.8 61.1 -12.6 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 N/A 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 0.0 0.0 287 222 0.0 0.0   Shareholders equity total   0.0 17.3 46,205 85.9 225 211 111 111   Interest-bearing liabilities   0.0 0.1 200,000 214 150 162 0.0 0.0   Balance sheet total (assets)   0.0 269 608,826 663 1,158 879 111 111   Net Debt   0.0 -7.9 199,342 208 108 133 -111 -111     See the entire balance sheet 1000.0 Volume  2018 N/A 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 42 0 0 0 0 0 0   Net sales growth   0.0% 0.0% -100.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   0.0 11.3 38,516 72.5 445 408 0.0 0.0   Gross profit growth   0.0% 0.0% 339,727.1% -99.8% 514.0% -8.4% -100.0% 0.0%   Employees   0 0 0 0 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   0 269 608,826 663 1,158 879 111 111   Balance sheet change%   0.0% 0.0% 226,381.8% -99.9% 74.6% -24.1% -87.4% 0.0%   Added value   0.0 11.3 38,516.0 72.5 148.8 105.3 0.0 0.0   Added value %   0.0% 27.2% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 0 222 -130 -222 0   Net sales trend   0.0 0.0 -1.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   0.0 1.0 2.0 3.0 4.0 5.0 0.0 0.0   1000.0 Profitability  2018 N/A 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 27.2% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 27.2% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   0.0% 100.0% 100.0% 100.0% 33.4% 9.9% 0.0% 0.0%   Net Earnings %   0.0% 17.4% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 17.4% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 22.3% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   0.0% 4.2% 12.6% 0.0% 16.4% 4.0% 0.0% 0.0%   ROI %   0.0% 65.5% 31.3% 0.1% 43.8% 10.7% 0.0% 0.0%   ROE %   0.0% 42.0% 125.3% 0.2% 27.5% -6.3% 0.0% 0.0%   1000.0 Solidity  2018 N/A 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   0.0% 6.4% 7.6% 13.0% 19.4% 24.0% 100.0% 100.0%   Relative indebtedness %   0.0% 603.7% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 584.5% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   0.0% -70.1% 517.6% 286.6% 50.5% 125.8% 0.0% 0.0%   Gearing %   0.0% 0.3% 432.9% 249.6% 66.7% 76.7% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 7,472.7% 1.4% 0.0% 48.2% 34.0% 0.0% 0.0%   1000.0 Liquidity  2018 N/A 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.0 0.7 0.5 0.5 0.5 0.2 0.0 0.0   Current Ratio   0.0 1.1 1.1 1.1 0.9 1.0 0.0 0.0   Cash and cash equivalent   0.0 8.0 658.0 6.5 42.0 29.5 0.0 0.0   1000.0 Capital use efficiency  2018 N/A 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 389.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 2,968.8 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 645.1% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   0.0 19.3 46,205.0 85.9 -56.5 -10.5 0.0 0.0   Net working capital %   0.0% 46.3% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 N/A 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 149 105 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 214 105 0 0   EBIT / employee   0 0 0 0 149 40 0 0   Net earnings / employee   0 0 0 0 43 -14 0 0